Last updated at 29 Jun 2024 11:53 PM
Director
DIN: 09104933
Sanjay Indermal Jain is currently associated with 2 companies in various capacities such as Individual Promoter, Managing Director and Director. They serve as a Director at RASHI PHARMA CARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09104933.Sanjay Indermal Jain is currently involved in 3 different roles. Their most recent position is with SHREEN BIOSCIENCES PRIVATE LIMITED as a Director. The first company Sanjay Indermal Jain was appointed to as a director was RASHI PHARMA CARE PRIVATE LIMITED. Sanjay Indermal Jain is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sanjay Indermal Jain is currently associated with 2 companies in various capacities such as Individual Promoter, Managing Director and Director. They serve as a Director at RASHI PHARMA CARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09104933.Sanjay Indermal Jain is currently involved in 3 different roles. Their most recent position is with SHREEN BIOSCIENCES PRIVATE LIMITED as a Director. The first company Sanjay Indermal Jain was appointed to as a director was RASHI PHARMA CARE PRIVATE LIMITED. Sanjay Indermal Jain is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1 Year 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| RASHI PHARMA CARE PRIVATE LIMITED | Individual Promoter | 13-Mar-2021 |
| RASHI PHARMA CARE PRIVATE LIMITED | Managing Director | 13-Mar-2021 |
| SHREEN BIOSCIENCES PRIVATE LIMITED | Director | 02-May-2024 |